Global Intravenous Solutions Market Growth 2025-2031

The global Intravenous Solutions market size is predicted to grow from US$ 12150 million in 2025 to US$ 17760 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.

In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

LP Information, Inc. (LPI) ' newest research report, the “Intravenous Solutions Industry Forecast” looks at past sales and reviews total world Intravenous Solutions sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous Solutions sales for 2025 through 2031. With Intravenous Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Solutions industry.

This Insight Report provides a comprehensive analysis of the global Intravenous Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravenous Solutions market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Solutions.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Solutions market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Crystalloids
Colloids
Others

Segmentation by Application:
Basic IV Solutions
Nutrient Infusion Solution
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
Fresenius Kabi
JW Life Science
B. Braun Melsungen

Key Questions Addressed in this Report

What is the 10-year outlook for the global Intravenous Solutions market?

What factors are driving Intravenous Solutions market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Intravenous Solutions market opportunities vary by end market size?

How does Intravenous Solutions break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.